long acting bronchodilators
Predicting treatable traits for long-acting bronchodilators in patients with stable COPD
... for long-acting bronchodilator treatment response in patients with ...all long- acting bronchodilators for at least 4 weeks, if they were using ...
9
<p>Relationship of inhaled long-acting bronchodilators with cardiovascular outcomes among patients with stable COPD: a meta-analysis and systematic review of 43 randomized trials</p>
... and long-acting β 2 – agonists (LABAs) are the mainstay of maintenance therapy for ...inhaled long- acting bronchodilators (ILABs), LABA and/or LAMA are recommended by the Global ...
10
Impact of prior and concurrent medication on exacerbation risk with long-acting bronchodilators in chronic obstructive pulmonary disease: a post hoc analysis
... 27]. Long-acting bronchodilators also have the potential to impact mucus secretions and mucocilli- ary clearance, and may have impacts on airway smooth muscle growth and airway fibrosis as well as ...
11
Adherence to current guidelines for chronic obstructive pulmonary disease (COPD) among patients treated with combination of long-acting bronchodilators or inhaled corticosteroids
... symptoms. Bronchodilators are central to such a therapeutic ...main bronchodilators are β 2 -agonists, anticholinergics, theophylline and a combination of these ...inhaled bronchodilators are ...
9
Long-acting bronchodilators improve exercise capacity in COPD patients: a systematic review and meta-analysis
... We selected randomized controlled studies (RCTs) focused on the efficacy of long-acting bronchodilators (i.e.: LABA, LAMA, LABA/ICS, and LABA/LAMA FDCs) on exercise capacity in COPD patients based on ...
12
How Do Dual Long-acting Bronchodilators Prevent Exacerbations of Chronic Obstructive Pulmonary Disease?
... of bronchodilators, resulting in symptom improvement, most notably reduced dyspnea (55, ...appropriate long-acting bronchodilators (LABD) treatment may thus lead to a greater difference ...
40
Major comorbidities lead to the risk of adverse cardiovascular events in chronic obstructive pulmonary disease patients using inhaled long-acting bronchodilators: a case-control study
... inhaled bronchodilators were regulated by guidelines and the data is based on retrospective chart ...inhaled bronchodilators does not imply cause and ...inhaled long-acting ...
10
Comparative efficacy of long-acting bronchodilators for COPD - a network meta-analysis
... alternative long-acting treat- ments available for COPD, clinicians are faced with an increasingly challenging choice regarding the optimal ...of long-acting bronchodilators in patients ...
18
Characteristics, disease burden and costs of COPD patients in the two years following initiation of long-acting bronchodilators in UK primary care
... The costs were expressed as mean annualised costs and were calculated using 2014 data (Table 1). The cost of a severe exacerbation was estimated using the National Health Service (NHS) reference costs 2013-14 (Health- ...
10
Dual combination therapy versus long-acting bronchodilators alone for chronic obstructive pulmonary disease (COPD) : A systematic review and network meta-analysis
... Short-acting bronchodilators are given on an as-needed basis to provide immediate relief, and long-acting bronchodila- tors are used as maintenance therapy in people with moderate to very ...
535
Comparison of efficacy of long-acting bronchodilators in emphysema dominant and emphysema nondominant chronic obstructive pulmonary disease
... between long-acting muscarinic antagonists and long-acting β 2-agonists when patients with COPD are divided into emphysema dominant and emphysema nondominant ...a long-acting ...
9
Comparison of resource use by COPD patients on inhaled therapies with long-acting bronchodilators: a database study
... This study was a retrospective, propensity matched- cohort treatment group comparison. An index date was assigned as the date of the first claim for tiotropium, formoterol or salmeterol [r] ...
9
Short Term Effects of Tiotropium on COPD Patients Treated with Long Acting Bronchodilators
... short- acting bronchodilator occurs in the majority of patients, approximately 100- 130 ml and this parameter is smaller than the threshold of 200 ml which is clinically considered significant ...
6
Differential pharmacology and clinical utility of long-acting bronchodilators in COPD – focus on olodaterol
... with a half-life of 32 minutes and the slow component (about 30%–40% of the total β 2 -AR pool) showing a half-life of dissociation of 17.8 hours, providing a rationale for a long duration of action. In fact, in ...
7
Long-acting bronchodilators with or without inhaled corticosteroids and 30-day readmission in patients hospitalized for COPD
... These findings taken together could merely reflect that sicker individuals are on maintenance drugs and sicker people get rehospitalized. The other explanation could be related to the differential mechanism of these ...
10
The effects of long-acting bronchodilators on total mortality in patients with stable chronic obstructive pulmonary disease
... the other hand, a secondary analysis of the UPLIFT trial suggested a mortality benefit [6]. Similarly, although the TORCH trial suggested a modest mortality benefit with inhaled corticosteroid/long-acting ...
13
Bronchodilator treatment of stable COPD: long-acting anticholinergics
... and long-acting anticholinergic agents was introduced for once-daily maintenance treatment of COPD ...large long-term randomised clinical trials comparing tiotropium to placebo as well as to the SAAC ...
9
Narcotic tapering in pregnancy using long-acting morphine
... communities also participated and were tapered on that medication (Table 2). Morphine-equivalent doses of narcotics were calculated by standard methods, and each patient was changed to an oral starting dose and seen ...
8
Long-Acting Reversible Contraception: Specific Issues for Adolescents
... counterparts (category 1) because of concerns related to higher expulsion risk and sexually transmitted infection (STI) rates. 4 Newer, well- conducted studies have refuted previous concerns associating IUD use and ...
14
Long-acting injectable antipsychotics: focus on olanzapine pamoate
... Twenty-nine cases (in 28 patients) of PDSS were identified and reviewed. The per-injection rate was calculated based on a total of 40,000 injections as 0.07% and a per-patient rate of 1.2%. The cumulative risk of ...
7